| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | -0.0099 | 0.9 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | -0.0042 | 0.9 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | 0.0055 | 0.9 |